Associated Papers
Whole-exome sequencing reveals genomic landscape of intrahepatic cholangiocarcinoma and identifies SAV1 as a potential driver.
Zhou ZJ et al.
Nature Communications, 2024
39551842 (PubMed )
Supplement: 41467_2024_54387_MOESM3_ESM.xlsx › Supplementary_Data_2
Saturation genome editing of BAP1 functionally classifies somatic and germline variants.
Waters AJ et al.
Nature Genetics, 2024
38969833 (PubMed )
Supplement: 41588_2024_1799_MOESM19_ESM.xlsx › extended_data_fig_7_j
Functional assay for assessment of pathogenicity of BAP1 variants.
Repo PE et al.
Human Molecular Genetics, 2024
Clear cell mesotheliomas with inactivating VHL mutations and near-haploid genomic features.
Michal M et al.
Genes, Chromosomes & Cancer, 2023
Prognostic Values of G-Protein Mutations in Metastatic Uveal Melanoma.
Terai M et al.
Cancers, 2021
34830903 (PubMed )
Supplement: cancers-13-05749-s001.zip › cancers-1393069-supplementary.pdf
Characterization of genetically defined sporadic and hereditary type 1 papillary renal cell carcinoma cell lines.
Yang Y et al.
Genes, Chromosomes & Cancer, 2021
Population-based analysis of BAP1 germline variations in patients with uveal melanoma.
Repo P et al.
Human Molecular Genetics, 2019
Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide.
Walpole S et al.
Journal of the National Cancer Institute, 2018
Prognostic value of chromosomal imbalances, gene mutations, and BAP1 expression in uveal melanoma.
Patrone S et al.
Genes, Chromosomes & Cancer, 2018
Systematic genomic and translational efficiency studies of uveal melanoma.
Johnson CP et al.
Plos One, 2017
28594900 (PubMed )
Supplement: pone.0178189.s003.xls › Sheet1
Select a paper to view details